Aurobindo Pharma has received an approval to acquire 25% equity stake in Silicon Life Sciences (Silicon), a company engaged in manufacture of non-sterile penems, from the existing shareholder – ABS Mercantiles. Post this acquisition, the equity holding of the company would increase to 100%, thereby making Silicon a wholly owned subsidiary of the company.
http://www.epicresearch.co/0731-664-2300
0 comments:
Post a Comment